BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

658 related articles for article (PubMed ID: 29685597)

  • 1. Brucellosis vaccines based on the open reading frames from genomic island 3 of Brucella abortus.
    Gómez L; Alvarez F; Betancur D; Oñate A
    Vaccine; 2018 May; 36(21):2928-2936. PubMed ID: 29685597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of protective effect of DNA vaccines encoding the BAB1_0263 and BAB1_0278 open reading frames of Brucella abortus in BALB/c mice.
    Sislema-Egas F; Céspedes S; Fernández P; Retamal-Díaz A; Sáez D; Oñate A
    Vaccine; 2012 Nov; 30(50):7286-91. PubMed ID: 23026687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of a DNA vaccine containing an open reading frame with homology to an ABC-type transporter present in the genomic island 3 of Brucella abortus in BALB/c mice.
    Riquelme-Neira R; Retamal-Díaz A; Acuña F; Riquelme P; Rivera A; Sáez D; Oñate A
    Vaccine; 2013 Aug; 31(36):3663-7. PubMed ID: 23834811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization of BALB/c mice with a combination of four recombinant Brucella abortus proteins, AspC, Dps, InpB and Ndk, confers a marked protection against a virulent strain of Brucella abortus.
    Hop HT; Arayan LT; Huy TXN; Reyes AWB; Min W; Lee HJ; Park SJ; Chang HH; Kim S
    Vaccine; 2018 May; 36(21):3027-3033. PubMed ID: 29678458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Booster vaccination with safe, modified, live-attenuated mutants of Brucella abortus strain RB51 vaccine confers protective immunity against virulent strains of B. abortus and Brucella canis in BALB/c mice.
    Truong QL; Cho Y; Kim K; Park BK; Hahn TW
    Microbiology (Reading); 2015 Nov; 161(11):2137-48. PubMed ID: 26341622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brucella abortus 2308ΔNodVΔNodW double-mutant is highly attenuated and confers protection against wild-type challenge in BALB/c mice.
    Li Z; Wang S; Zhang J; Yang G; Yuan B; Huang J; Han J; Xi L; Xiao Y; Chen C; Zhang H
    Microb Pathog; 2017 May; 106():30-39. PubMed ID: 28131952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-infectious outer membrane vesicles derived from Brucella abortus S19Δper as an alternative acellular vaccine protects mice against virulent challenge.
    Solanki KS; Varshney R; Qureshi S; Thomas P; Singh R; Agrawal A; Chaudhuri P
    Int Immunopharmacol; 2021 Jan; 90():107148. PubMed ID: 33189614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rough vaccines in animal brucellosis: structural and genetic basis and present status.
    Moriyón I; Grilló MJ; Monreal D; González D; Marín C; López-Goñi I; Mainar-Jaime RC; Moreno E; Blasco JM
    Vet Res; 2004; 35(1):1-38. PubMed ID: 15099501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
    Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein/Protein, DNA/DNA and DNA/Protein based vaccination strategies using truncated Omp2b against Brucella infection in BALB/c Mice.
    Golshani M; Rafati S; Nejati-Moheimani M; Pourabdi S; Arsang A; Bouzari S
    Int J Med Microbiol; 2017 Jun; 307(4-5):249-256. PubMed ID: 28391992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multivalent Fusion DNA Vaccine against
    Gómez L; Llanos J; Escalona E; Sáez D; Álvarez F; Molina R; Flores M; Oñate A
    Biomed Res Int; 2017; 2017():6535479. PubMed ID: 29082252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A combined subunit vaccine comprising BP26, Omp25 and L7/L12 against brucellosis.
    Gupta S; Singh D; Gupta M; Bhatnagar R
    Pathog Dis; 2019 Nov; 77(8):. PubMed ID: 31971564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune response triggered by Brucella abortus following infection or vaccination.
    Dorneles EM; Teixeira-Carvalho A; Araújo MS; Sriranganathan N; Lage AP
    Vaccine; 2015 Jul; 33(31):3659-66. PubMed ID: 26048781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants.
    Grilló MJ; Manterola L; de Miguel MJ; Muñoz PM; Blasco JM; Moriyón I; López-Goñi I
    Vaccine; 2006 Apr; 24(15):2910-6. PubMed ID: 16439039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza viral vectors expressing the Brucella OMP16 or L7/L12 proteins as vaccines against B. abortus infection.
    Tabynov K; Sansyzbay A; Kydyrbayev Z; Yespembetov B; Ryskeldinova S; Zinina N; Assanzhanova N; Sultankulova K; Sandybayev N; Khairullin B; Kuznetsova I; Ferko B; Egorov A
    Virol J; 2014 Apr; 11():69. PubMed ID: 24716528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of adenovirus and DNA vaccines co-expressing P39 and lumazine synthase proteins of Brucella abortus in BALB/c mice.
    Lin GZ; Yang JT; Wei SC; Chen SE; Huo SD; Ma ZR
    Trop Anim Health Prod; 2018 Jun; 50(5):957-963. PubMed ID: 29492808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brucella abortus mutants lacking ATP-binding cassette transporter proteins are highly attenuated in virulence and confer protective immunity against virulent B. abortus challenge in BALB/c mice.
    Truong QL; Cho Y; Park S; Park BK; Hahn TW
    Microb Pathog; 2016 Jun; 95():175-185. PubMed ID: 27057678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with recombinant GntR plasmid confers protection against Brucella challenge in BALB/c mice.
    Li Z; Wang S; Zhang H; Xi L; Zhang J; Zhang X; Han J; Zhang J
    Microb Pathog; 2017 Oct; 111():357-361. PubMed ID: 28916314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitope-Based Vaccine of a
    Oliveira KC; Brancaglion GA; Santos NCM; Araújo LP; Novaes E; Santos RL; Oliveira SC; Corsetti PP; de Almeida LA
    Front Immunol; 2021; 12():778475. PubMed ID: 34992597
    [No Abstract]   [Full Text] [Related]  

  • 20. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
    Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
    Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.